生物学如何改变了药物发现景观
1Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA;
Annual review of pharmacology and toxicology
|October 10, 2024
概括
由分子生物学和免疫学的进步推动的生物疗法改变了药物发现和开发. 未来的进化包括mRNA疗法和AI应用.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子遗传学 分子遗传学
背景情况:
- 由于分子生物学,遗传学,免疫学和瘤学的突破,生物疗法迅速发展.
- 这些进展显著重塑了整个药物发现和开发管道.
研究的目的:
- 概述生物疗法对药物发现和开发过程的影响.
- 突出生物制剂的制造,安全和临床试验的复杂性和必要的调整.
- 预测未来的趋势,包括mRNA疗法和人工智能.
主要方法:
- 生物制品是由生物体生产的.
- 查库是通过免疫或菌体显示生成的.
- 优化采用先进的蛋白质工程来增强药物特性和特异性.
主要成果:
- 制造生物制剂是复杂的,需要专门的设施.
- 鉴于物种的特异性,评估药理学和安全性存在挑战.
- 临床试验需要更谨慎的方法,因为临床前数据的可预测性有限.
结论:
- 生物疗法从根本上改变了药物的发现和开发.
- 该领域已准备好与mRNA疗法和AI等新兴技术进一步发展.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.7K
相关概念视频
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
Bioequivalence: Overview
932
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
932
